{"meta":{"query_hash":"5fa6b88e9eac","filters":{"venue":"Biopharma Dealmakers"},"cohort_total":4,"direct_labels_cover":0,"predictions_cover":4,"exported":4,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/5fa6b88e9eac","api":"https://metacan.xera.ac/api/v1/cohort?venue=Biopharma+Dealmakers"},"results":[{"id":"W4379013809","doi":"10.1038/d43747-023-00062-8","title":"A formula for drug licensing deals","year":2023,"lang":"en","type":"article","venue":"Biopharma Dealmakers","topic":"Biotechnology and Related Fields","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trinity College","funders":"","keywords":"Value (mathematics); Mathematical model; Computer science; Management science; Mathematical economics; Mathematics; Econometrics; Statistics; Engineering","score_opus":0.026615124406594245,"score_gpt":0.3284197357351395,"score_spread":0.30180461132854525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379013809","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0070178127,0.0038720004,0.028280536,0.23946196,0.020973817,0.00044378918,0.0004053495,0.0008969894,0.6986478],"genre_scores_gemma":[0.19965003,0.0028147034,0.018652394,0.10450851,0.013426585,0.00093681866,0.00027509287,0.00076572114,0.65897],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.99355906,0.001013692,0.00025831634,0.000800734,0.0036098845,0.0007583894],"domain_scores_gemma":[0.9871158,0.005171312,0.0005948146,0.001641563,0.0044360235,0.0010404252],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005134452,0.0010979855,0.0009435927,0.0032646938,0.0061311,0.012085932,0.0020395487,0.017829139,0.05458852],"category_scores_gemma":[0.038823254,0.0009723216,0.001214616,0.0012640721,0.0077250116,0.016190844,0.0045517343,0.01682001,0.015842395],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000021195172,0.000043760225,0.00014899412,0.00003143492,0.0000059063286,0.00006548109,0.00012077724,0.00010555838,0.00015584636,0.8658554,0.116975226,0.016470429],"study_design_scores_gemma":[0.000095969735,0.00008126364,0.0004652978,0.00026168732,0.000028915514,0.000117108284,0.00024528123,0.001067866,0.0003614279,0.41961476,0.57760626,0.000054166252],"about_ca_topic_score_codex":0.00806463,"about_ca_topic_score_gemma":0.010375376,"teacher_disagreement_score":0.05458852,"about_ca_system_score_codex":0.0057896455,"about_ca_system_score_gemma":0.0079863435,"threshold_uncertainty_score":0.18261683},"labels":[],"label_agreement":null},{"id":"W4399300384","doi":"10.1038/d43747-024-00027-5","title":"Top ten biopharma deals of 2024","year":2024,"lang":"en","type":"article","venue":"Biopharma Dealmakers","topic":"Science, Research, and Medicine","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quarter (Canadian coin); Value (mathematics); Business; Engineering; Geography; Computer science","score_opus":0.032967318924716695,"score_gpt":0.37500310724981883,"score_spread":0.3420357883251021,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399300384","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013994561,0.016634079,0.0013136878,0.026966631,0.014087558,0.00030456096,0.008243647,0.0010152524,0.9174402],"genre_scores_gemma":[0.025523094,0.0054245703,0.000987171,0.006823394,0.0028233808,0.00012678251,0.0049062157,0.00017871291,0.9532066],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977191,0.00020930075,0.00009028127,0.00020374847,0.0013149026,0.00046266013],"domain_scores_gemma":[0.99761534,0.00027363645,0.00018775988,0.00009152763,0.0007586926,0.0010729496],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001608821,0.001033208,0.0006530157,0.0032735285,0.0018031304,0.008014834,0.0007021898,0.0032694999,0.20881188],"category_scores_gemma":[0.0038210333,0.000542378,0.00072504167,0.0018767569,0.00056334236,0.0021976796,0.0019981072,0.0024309612,0.13584402],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029418076,0.00015082597,0.002487645,0.0003036572,0.00003183634,0.00023751936,0.000053338877,0.00010417383,0.0026654578,0.0150670055,0.8610558,0.1175485],"study_design_scores_gemma":[0.000020986612,0.00005426621,0.003019778,0.00007725069,0.000009040479,0.000106778025,0.000071029106,0.00008900265,0.0005794709,0.0009281872,0.99503595,0.0000082194],"about_ca_topic_score_codex":0.0021774804,"about_ca_topic_score_gemma":0.0051757805,"teacher_disagreement_score":0.20881188,"about_ca_system_score_codex":0.00174482,"about_ca_system_score_gemma":0.0046442193,"threshold_uncertainty_score":0.69854534},"labels":[],"label_agreement":null},{"id":"W4406798987","doi":"10.1038/d43747-024-00141-4","title":"Building a global biotechnology powerhouse in Canada","year":2025,"lang":"en","type":"article","venue":"Biopharma Dealmakers","topic":"Biotechnology and Related Fields","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Government of New Brunswick","funders":"","keywords":"Biotechnology; Political science; Engineering; Biology","score_opus":0.004728838199284108,"score_gpt":0.26356437334161514,"score_spread":0.25883553514233104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406798987","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.107394435,0.005637991,0.011756464,0.28555286,0.0034341135,0.0008658723,0.0009930532,0.0006529885,0.5837122],"genre_scores_gemma":[0.4501671,0.005077491,0.014938677,0.038562763,0.00036888733,0.00017276479,0.0006167934,0.00023309606,0.48986247],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9963588,0.00022276219,0.000045516063,0.0002725022,0.0015697504,0.0015306519],"domain_scores_gemma":[0.9910262,0.00056177314,0.00013914319,0.00016652005,0.002959385,0.005146914],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032542155,0.00042719464,0.00023977396,0.002021529,0.012907982,0.0099835135,0.0014933208,0.0037275315,0.024779515],"category_scores_gemma":[0.0047448617,0.0005111261,0.00062572584,0.0018186737,0.004249891,0.003183302,0.0040762136,0.0044299318,0.0015964434],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016707515,0.00047778097,0.014199915,0.00033340097,0.000060855702,0.0026549809,0.0045567383,0.004092639,0.005848575,0.4701148,0.3538314,0.14366189],"study_design_scores_gemma":[0.000038740192,0.000057006066,0.0063589863,0.00009573287,0.000015742035,0.00007879218,0.0036247722,0.0010644216,0.0012244999,0.008506518,0.97889733,0.000037540765],"about_ca_topic_score_codex":0.9593658,"about_ca_topic_score_gemma":0.9864824,"teacher_disagreement_score":0.9099253,"about_ca_system_score_codex":0.09007472,"about_ca_system_score_gemma":0.36487845,"threshold_uncertainty_score":0.65354085},"labels":[],"label_agreement":null},{"id":"W4416852000","doi":"10.1038/d43747-025-00111-4","title":"The year of the bispecific in oncology and beyond","year":2025,"lang":"en","type":"article","venue":"Biopharma Dealmakers","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Bispecific antibody; Quarter (Canadian coin); Antibody therapy; Radiation oncology; Momentum (technical analysis)","score_opus":0.015380649526590113,"score_gpt":0.3433365801308608,"score_spread":0.3279559306042707,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416852000","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0037160683,0.16526262,0.0036513838,0.41334212,0.32898957,0.00004850599,0.0005314789,0.00016707179,0.08429118],"genre_scores_gemma":[0.07578703,0.13079923,0.00571978,0.24926342,0.113227054,0.00011956847,0.0006402267,0.00045149226,0.42399222],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9963283,0.00064568437,0.0001789555,0.0005206574,0.0016415812,0.00068488484],"domain_scores_gemma":[0.98968303,0.002500893,0.00052323716,0.0006068509,0.0034220633,0.0032638707],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01282332,0.0009126694,0.00095770124,0.002098844,0.002271013,0.010270357,0.0013013186,0.007644441,0.020816285],"category_scores_gemma":[0.014882947,0.0005356243,0.0008607891,0.0019736025,0.006526719,0.0075074467,0.0036382366,0.012050821,0.0058043287],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021914802,0.000087313325,0.00043958428,0.00020689082,0.000015964026,0.00020178812,0.00026529861,0.000119438344,0.00086795236,0.1247465,0.8064744,0.066355646],"study_design_scores_gemma":[0.0000075984412,0.000037259648,0.00016288753,0.00008025282,0.000002994215,0.00006719637,0.00012140173,0.00003231234,0.0001808834,0.0035256948,0.99577445,0.000007122938],"about_ca_topic_score_codex":0.0065956647,"about_ca_topic_score_gemma":0.012377121,"teacher_disagreement_score":0.020816285,"about_ca_system_score_codex":0.007456944,"about_ca_system_score_gemma":0.0077477572,"threshold_uncertainty_score":0.06963748},"labels":[],"label_agreement":null}]}